IL129936A0 - Pharmaceutical compositions containing n-sulphonyl indolin derivatives - Google Patents

Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Info

Publication number
IL129936A0
IL129936A0 IL12993697A IL12993697A IL129936A0 IL 129936 A0 IL129936 A0 IL 129936A0 IL 12993697 A IL12993697 A IL 12993697A IL 12993697 A IL12993697 A IL 12993697A IL 129936 A0 IL129936 A0 IL 129936A0
Authority
IL
Israel
Prior art keywords
sulphonyl
pharmaceutical compositions
compositions containing
indolin derivatives
indolin
Prior art date
Application number
IL12993697A
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL129936A0 publication Critical patent/IL129936A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL12993697A 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives IL129936A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (en) 1996-12-05 1996-12-05 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES
PCT/FR1997/002210 WO1998024430A1 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Publications (1)

Publication Number Publication Date
IL129936A0 true IL129936A0 (en) 2000-02-29

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12993697A IL129936A0 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (en)
JP (1) JP2000507618A (en)
KR (1) KR20000069308A (en)
CN (1) CN1239887A (en)
AR (1) AR009651A1 (en)
AU (1) AU716575B2 (en)
BR (1) BR9712406A (en)
CA (1) CA2273990A1 (en)
CO (1) CO4910129A1 (en)
DZ (1) DZ2362A1 (en)
EE (1) EE9900206A (en)
FR (1) FR2756736B1 (en)
HU (1) HUP0001386A3 (en)
ID (1) ID23373A (en)
IL (1) IL129936A0 (en)
IS (1) IS5062A (en)
MY (1) MY132819A (en)
NO (1) NO992724D0 (en)
NZ (1) NZ335750A (en)
RU (1) RU2174394C2 (en)
SK (1) SK75599A3 (en)
TR (1) TR199901702T2 (en)
WO (1) WO1998024430A1 (en)
YU (1) YU23099A (en)
ZA (1) ZA9710919B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (en) * 1998-11-16 2000-12-08 Sanofi Sa PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
FR2805992A1 (en) * 2000-03-08 2001-09-14 Sanofi Synthelabo Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en) * 2001-06-26 2002-12-26 Farmatron Ltd ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (en) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139339B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound
KR102139338B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
ZA9710919B (en) 1999-06-04
DZ2362A1 (en) 2002-12-28
TR199901702T2 (en) 1999-09-21
CN1239887A (en) 1999-12-29
JP2000507618A (en) 2000-06-20
SK75599A3 (en) 2000-08-14
AU716575B2 (en) 2000-03-02
FR2756736A1 (en) 1998-06-12
WO1998024430A1 (en) 1998-06-11
CA2273990A1 (en) 1998-06-11
RU2174394C2 (en) 2001-10-10
IS5062A (en) 1999-06-01
KR20000069308A (en) 2000-11-25
NO992724L (en) 1999-06-04
NO992724D0 (en) 1999-06-04
AU5326298A (en) 1998-06-29
NZ335750A (en) 2001-06-29
MY132819A (en) 2007-10-31
BR9712406A (en) 1999-08-31
AR009651A1 (en) 2000-04-26
EP0941090A1 (en) 1999-09-15
CO4910129A1 (en) 2000-04-24
YU23099A (en) 1999-11-22
ID23373A (en) 2000-04-20
EE9900206A (en) 1999-12-15
HUP0001386A3 (en) 2002-03-28
FR2756736B1 (en) 1999-03-05
HUP0001386A2 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
IL111314A (en) Pharmaceutical compositions containing indole derivatives
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
HUP9903952A3 (en) Water soluble pharmaceutical compositions containing taxane derivatives
IL181059A0 (en) Pharmaceutical compositions containing isoflavones
HUP0002183A3 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
IL133605A0 (en) Solid pharmaceutical composition containing benzofuran derivatives
EG24118A (en) Pharmaceutical compositions
HUP9900424A2 (en) Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
HUP0004071A3 (en) Pharmaceutical compositions comprising prostaglandin derivatives
GB9616672D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
IL129936A0 (en) Pharmaceutical compositions containing n-sulphonyl indolin derivatives
ZA979726B (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
HUP0001441A3 (en) Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives
GB9618376D0 (en) Pharmaceutical compositions
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
GB9610136D0 (en) Pharmaceutical compositions
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols
ZA974125B (en) Oral pharmaceutical compositions
IL132784A0 (en) Pharmaceutical compositions containing dronabinol

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)